**Core Concept**
B-type natriuretic peptide (BNP) and its N-terminal pro-hormone (NT-proBNP) are biomarkers that play a crucial role in the diagnosis and management of heart failure. Elevated levels of these peptides are associated with increased ventricular wall stress, which is a hallmark of heart failure.

**Why the Correct Answer is Right**
The most commonly used assay for diagnosing heart failure is the NT-proBNP test. This test measures the levels of NT-proBNP in the blood, which are released from the ventricles in response to increased stretch and pressure. Elevated NT-proBNP levels are highly sensitive and specific for heart failure, particularly for identifying patients with acute decompensated heart failure. NT-proBNP levels are also useful for monitoring the progression of heart failure and guiding treatment decisions.

**Why Each Wrong Option is Incorrect**
* **Option A:** Troponin is a biomarker for cardiac injury, not heart failure. While troponin can be elevated in patients with heart failure, it is not specific for diagnosing heart failure.
* **Option B:** Creatinine kinase (CK) is a biomarker for muscle damage, including cardiac muscle damage. However, CK is not specific for heart failure and can be elevated in a variety of conditions, including skeletal muscle injury.
* **Option C:** Myoglobin is a biomarker for muscle damage, including cardiac muscle damage. However, myoglobin is not specific for heart failure and can be elevated in a variety of conditions, including skeletal muscle injury.

**Clinical Pearl / High-Yield Fact**
NT-proBNP levels can be elevated in conditions other than heart failure, such as pulmonary embolism, pneumonia, and chronic kidney disease.

**Correct Answer:** C.